Detalles de la búsqueda
1.
Efficacy and safety of fixed-dose combination of Bilastine-Montelukast in adult patients with allergic rhinitis: a phase III, randomized, multi-center, double-blind, active controlled clinical study.
J Asthma
; 60(11): 2014-2020, 2023 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-37140964
2.
Evaluation of the Efficacy and Safety of Azilsartan in Adult Patients with Essential Hypertension: A Randomized, Phase-III Clinical Study in India.
J Assoc Physicians India
; 69(2): 35-39, 2021 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-33527809
3.
A Real-World Study of Safety, Immunogenicity and Efficacy of Bevacizumab in Patients With Solid Malignancies: A Phase IV, Post-Marketing Study in India.
Cancer Inform
; 22: 11769351231177277, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37313371
4.
Efficacy and Safety of Molnupiravir in Mild COVID-19 Patients in India.
Cureus
; 14(11): e31508, 2022 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-36532902
5.
Safety, Tolerability, and Immunogenicity of Prescribed Usage of Darbepoetin-Alfa (Hetero Biopharma) in Patients of Chronic Kidney Disease With Renal Anemia: A Post-Marketing Surveillance Study.
Cureus
; 13(4): e14730, 2021 Apr 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34079677
6.
Efficacy and Safety of Acotiamide Versus Mosapride in Patients With Functional Dyspepsia Associated With Meal-Induced Postprandial Distress Syndrome: A Phase III Randomized Clinical Trial.
Cureus
; 13(9): e18109, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-34692320
7.
A Phase III Prospective Active and Placebo-Controlled Randomized Trial of Vilazodone in the Treatment of Major Depressive Disorder.
Cureus
; 13(7): e16689, 2021 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-34513348
8.
Efficacy and Safety of Orally Administered Acotiamide Extended-Release Tablets Among Functional Dyspepsia-Postprandial Distress Syndrome Patients: A Randomized, Double-Blind, Multicenter Study.
Cureus
; 13(4): e14361, 2021 Apr 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33968542
9.
Comparative evaluation of efficacy, pharmacodynamics, and safety of Hetero's adalimumab (Mabura®, Hetero Biopharma Ltd.) and reference adalimumab (Humira®, Abbvie Inc.) in patients with active rheumatoid arthritis on concomitant methotrexate therapy.
BMC Rheumatol
; 4: 24, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32518895
Resultados
1 -
9
de 9
1
Próxima >
>>